HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute ischemic stroke

In humans, a major component of natural killer (NK) and T cell target recognition depends on the surveillance of human leukocyte antigen (HLA) class I molecules by killer immunoglobulin-like receptors (KIRs). To implement the knowledge about the immunological genetic background of acute ischemic str...

Full description

Saved in:
Bibliographic Details
Published inJournal of neuroinflammation Vol. 16; no. 1; pp. 88 - 15
Main Authors Tuttolomondo, Antonino, Di Raimondo, Domenico, Pecoraro, Rosaria, Casuccio, Alessandra, Di Bona, Danilo, Aiello, Anna, Accardi, Giulia, Arnao, Valentina, Clemente, Giuseppe, Corte, Vittoriano Della, Maida, Carlo, Simonetta, Irene, Caruso, Calogero, Squatrito, Rosario, Pinto, Antonio
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 17.04.2019
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract In humans, a major component of natural killer (NK) and T cell target recognition depends on the surveillance of human leukocyte antigen (HLA) class I molecules by killer immunoglobulin-like receptors (KIRs). To implement the knowledge about the immunological genetic background of acute ischemic stroke susceptibility in relation to the frequency of the KIR genes and HLA alleles. Subjects with acute ischemic stroke and subjects without stroke were genotyped for the presence of KIR genes and of the three major KIR ligand groups, HLA-C1, HLA-C2, and HLA-Bw4, both HLA-B and HLA-A loci. Between November 2013 and February 2016, consecutive patients with acute ischemic stroke were recruited. As healthy controls, we enrolled subjects without acute ischemic stroke. Subjects with acute ischemic stroke in comparison with controls showed a higher frequency of 2DL3, 2DL5B, 2DS2, and 2DS4 KIR genes and a lower frequency of HLA-B-Bw4 alleles. Subjects without acute ischemic stroke showed a higher frequency of interaction between KIR 2DS2 and HLAC2. We also observed a higher frequency of 2DL3 and 2 DL4 KIR genes in subjects with atherosclerotic (LAAS) subtype. Multiple logistic regression analysis showed a protective effect towards stroke of HLA-B-Bw4 and interaction between KIR 2DL2 and HLAC1 and 2DS2-HLAC2 and a detrimental effect of 2DL2-HLA-C1_A interactions. Our findings of a higher frequency of activating KIR genes seem to be consistent with findings previously reported patients with coronary syndrome. This higher frequency of "proinflammatory" genes in subjects with ischemic stroke could also explain the immunoinflammatory activation of the acute phase of stroke.
AbstractList In humans, a major component of natural killer (NK) and T cell target recognition depends on the surveillance of human leukocyte antigen (HLA) class I molecules by killer immunoglobulin-like receptors (KIRs).INTRODUCTIONIn humans, a major component of natural killer (NK) and T cell target recognition depends on the surveillance of human leukocyte antigen (HLA) class I molecules by killer immunoglobulin-like receptors (KIRs).To implement the knowledge about the immunological genetic background of acute ischemic stroke susceptibility in relation to the frequency of the KIR genes and HLA alleles.AIMSTo implement the knowledge about the immunological genetic background of acute ischemic stroke susceptibility in relation to the frequency of the KIR genes and HLA alleles.Subjects with acute ischemic stroke and subjects without stroke were genotyped for the presence of KIR genes and of the three major KIR ligand groups, HLA-C1, HLA-C2, and HLA-Bw4, both HLA-B and HLA-A loci.METHODSSubjects with acute ischemic stroke and subjects without stroke were genotyped for the presence of KIR genes and of the three major KIR ligand groups, HLA-C1, HLA-C2, and HLA-Bw4, both HLA-B and HLA-A loci.Between November 2013 and February 2016, consecutive patients with acute ischemic stroke were recruited. As healthy controls, we enrolled subjects without acute ischemic stroke. Subjects with acute ischemic stroke in comparison with controls showed a higher frequency of 2DL3, 2DL5B, 2DS2, and 2DS4 KIR genes and a lower frequency of HLA-B-Bw4I alleles. Subjects without acute ischemic stroke showed a higher frequency of interaction between KIR 2DS2 and HLAC2. We also observed a higher frequency of 2DL3 and 2 DL4 KIR genes in subjects with atherosclerotic (LAAS) subtype. Multiple logistic regression analysis showed a protective effect towards stroke of HLA-B-Bw4I and interaction between KIR 2DL2 and HLAC1 and 2DS2-HLAC2 and a detrimental effect of 2DL2-HLA-C1_A interactions.RESULTSBetween November 2013 and February 2016, consecutive patients with acute ischemic stroke were recruited. As healthy controls, we enrolled subjects without acute ischemic stroke. Subjects with acute ischemic stroke in comparison with controls showed a higher frequency of 2DL3, 2DL5B, 2DS2, and 2DS4 KIR genes and a lower frequency of HLA-B-Bw4I alleles. Subjects without acute ischemic stroke showed a higher frequency of interaction between KIR 2DS2 and HLAC2. We also observed a higher frequency of 2DL3 and 2 DL4 KIR genes in subjects with atherosclerotic (LAAS) subtype. Multiple logistic regression analysis showed a protective effect towards stroke of HLA-B-Bw4I and interaction between KIR 2DL2 and HLAC1 and 2DS2-HLAC2 and a detrimental effect of 2DL2-HLA-C1_A interactions.Our findings of a higher frequency of activating KIR genes seem to be consistent with findings previously reported patients with coronary syndrome. This higher frequency of "proinflammatory" genes in subjects with ischemic stroke could also explain the immunoinflammatory activation of the acute phase of stroke.CONCLUSIONOur findings of a higher frequency of activating KIR genes seem to be consistent with findings previously reported patients with coronary syndrome. This higher frequency of "proinflammatory" genes in subjects with ischemic stroke could also explain the immunoinflammatory activation of the acute phase of stroke.
Introduction In humans, a major component of natural killer (NK) and T cell target recognition depends on the surveillance of human leukocyte antigen (HLA) class I molecules by killer immunoglobulin-like receptors (KIRs). Aims To implement the knowledge about the immunological genetic background of acute ischemic stroke susceptibility in relation to the frequency of the KIR genes and HLA alleles. Methods Subjects with acute ischemic stroke and subjects without stroke were genotyped for the presence of KIR genes and of the three major KIR ligand groups, HLA-C1, HLA-C2, and HLA-Bw4, both HLA-B and HLA-A loci. Results Between November 2013 and February 2016, consecutive patients with acute ischemic stroke were recruited. As healthy controls, we enrolled subjects without acute ischemic stroke. Subjects with acute ischemic stroke in comparison with controls showed a higher frequency of 2DL3, 2DL5B, 2DS2, and 2DS4 KIR genes and a lower frequency of HLA-B-Bw4I alleles. Subjects without acute ischemic stroke showed a higher frequency of interaction between KIR 2DS2 and HLAC2. We also observed a higher frequency of 2DL3 and 2 DL4 KIR genes in subjects with atherosclerotic (LAAS) subtype. Multiple logistic regression analysis showed a protective effect towards stroke of HLA-B-Bw4I and interaction between KIR 2DL2 and HLAC1 and 2DS2-HLAC2 and a detrimental effect of 2DL2-HLA-C1_A interactions. Conclusion Our findings of a higher frequency of activating KIR genes seem to be consistent with findings previously reported patients with coronary syndrome. This higher frequency of “proinflammatory” genes in subjects with ischemic stroke could also explain the immunoinflammatory activation of the acute phase of stroke.
In humans, a major component of natural killer (NK) and T cell target recognition depends on the surveillance of human leukocyte antigen (HLA) class I molecules by killer immunoglobulin-like receptors (KIRs). To implement the knowledge about the immunological genetic background of acute ischemic stroke susceptibility in relation to the frequency of the KIR genes and HLA alleles. Subjects with acute ischemic stroke and subjects without stroke were genotyped for the presence of KIR genes and of the three major KIR ligand groups, HLA-C1, HLA-C2, and HLA-Bw4, both HLA-B and HLA-A loci. Between November 2013 and February 2016, consecutive patients with acute ischemic stroke were recruited. As healthy controls, we enrolled subjects without acute ischemic stroke. Subjects with acute ischemic stroke in comparison with controls showed a higher frequency of 2DL3, 2DL5B, 2DS2, and 2DS4 KIR genes and a lower frequency of HLA-B-Bw4 alleles. Subjects without acute ischemic stroke showed a higher frequency of interaction between KIR 2DS2 and HLAC2. We also observed a higher frequency of 2DL3 and 2 DL4 KIR genes in subjects with atherosclerotic (LAAS) subtype. Multiple logistic regression analysis showed a protective effect towards stroke of HLA-B-Bw4 and interaction between KIR 2DL2 and HLAC1 and 2DS2-HLAC2 and a detrimental effect of 2DL2-HLA-C1_A interactions. Our findings of a higher frequency of activating KIR genes seem to be consistent with findings previously reported patients with coronary syndrome. This higher frequency of "proinflammatory" genes in subjects with ischemic stroke could also explain the immunoinflammatory activation of the acute phase of stroke.
In humans, a major component of natural killer (NK) and T cell target recognition depends on the surveillance of human leukocyte antigen (HLA) class I molecules by killer immunoglobulin-like receptors (KIRs). To implement the knowledge about the immunological genetic background of acute ischemic stroke susceptibility in relation to the frequency of the KIR genes and HLA alleles. Subjects with acute ischemic stroke and subjects without stroke were genotyped for the presence of KIR genes and of the three major KIR ligand groups, HLA-C1, HLA-C2, and HLA-Bw4, both HLA-B and HLA-A loci. Between November 2013 and February 2016, consecutive patients with acute ischemic stroke were recruited. As healthy controls, we enrolled subjects without acute ischemic stroke. Subjects with acute ischemic stroke in comparison with controls showed a higher frequency of 2DL3, 2DL5B, 2DS2, and 2DS4 KIR genes and a lower frequency of HLA-B-Bw4.sup.I alleles. Subjects without acute ischemic stroke showed a higher frequency of interaction between KIR 2DS2 and HLAC2. We also observed a higher frequency of 2DL3 and 2 DL4 KIR genes in subjects with atherosclerotic (LAAS) subtype. Multiple logistic regression analysis showed a protective effect towards stroke of HLA-B-Bw4.sup.I and interaction between KIR 2DL2 and HLAC1 and 2DS2-HLAC2 and a detrimental effect of 2DL2-HLA-C1_A interactions. Our findings of a higher frequency of activating KIR genes seem to be consistent with findings previously reported patients with coronary syndrome. This higher frequency of "proinflammatory" genes in subjects with ischemic stroke could also explain the immunoinflammatory activation of the acute phase of stroke.
Abstract Introduction In humans, a major component of natural killer (NK) and T cell target recognition depends on the surveillance of human leukocyte antigen (HLA) class I molecules by killer immunoglobulin-like receptors (KIRs). Aims To implement the knowledge about the immunological genetic background of acute ischemic stroke susceptibility in relation to the frequency of the KIR genes and HLA alleles. Methods Subjects with acute ischemic stroke and subjects without stroke were genotyped for the presence of KIR genes and of the three major KIR ligand groups, HLA-C1, HLA-C2, and HLA-Bw4, both HLA-B and HLA-A loci. Results Between November 2013 and February 2016, consecutive patients with acute ischemic stroke were recruited. As healthy controls, we enrolled subjects without acute ischemic stroke. Subjects with acute ischemic stroke in comparison with controls showed a higher frequency of 2DL3, 2DL5B, 2DS2, and 2DS4 KIR genes and a lower frequency of HLA-B-Bw4I alleles. Subjects without acute ischemic stroke showed a higher frequency of interaction between KIR 2DS2 and HLAC2. We also observed a higher frequency of 2DL3 and 2 DL4 KIR genes in subjects with atherosclerotic (LAAS) subtype. Multiple logistic regression analysis showed a protective effect towards stroke of HLA-B-Bw4I and interaction between KIR 2DL2 and HLAC1 and 2DS2-HLAC2 and a detrimental effect of 2DL2-HLA-C1_A interactions. Conclusion Our findings of a higher frequency of activating KIR genes seem to be consistent with findings previously reported patients with coronary syndrome. This higher frequency of “proinflammatory” genes in subjects with ischemic stroke could also explain the immunoinflammatory activation of the acute phase of stroke.
Introduction In humans, a major component of natural killer (NK) and T cell target recognition depends on the surveillance of human leukocyte antigen (HLA) class I molecules by killer immunoglobulin-like receptors (KIRs). Aims To implement the knowledge about the immunological genetic background of acute ischemic stroke susceptibility in relation to the frequency of the KIR genes and HLA alleles. Methods Subjects with acute ischemic stroke and subjects without stroke were genotyped for the presence of KIR genes and of the three major KIR ligand groups, HLA-C1, HLA-C2, and HLA-Bw4, both HLA-B and HLA-A loci. Results Between November 2013 and February 2016, consecutive patients with acute ischemic stroke were recruited. As healthy controls, we enrolled subjects without acute ischemic stroke. Subjects with acute ischemic stroke in comparison with controls showed a higher frequency of 2DL3, 2DL5B, 2DS2, and 2DS4 KIR genes and a lower frequency of HLA-B-Bw4.sup.I alleles. Subjects without acute ischemic stroke showed a higher frequency of interaction between KIR 2DS2 and HLAC2. We also observed a higher frequency of 2DL3 and 2 DL4 KIR genes in subjects with atherosclerotic (LAAS) subtype. Multiple logistic regression analysis showed a protective effect towards stroke of HLA-B-Bw4.sup.I and interaction between KIR 2DL2 and HLAC1 and 2DS2-HLAC2 and a detrimental effect of 2DL2-HLA-C1_A interactions. Conclusion Our findings of a higher frequency of activating KIR genes seem to be consistent with findings previously reported patients with coronary syndrome. This higher frequency of "proinflammatory" genes in subjects with ischemic stroke could also explain the immunoinflammatory activation of the acute phase of stroke. Keywords: Stroke, Killer immunoglobulin-like receptors (KIRs), HLA
ArticleNumber 88
Audience Academic
Author Di Bona, Danilo
Tuttolomondo, Antonino
Di Raimondo, Domenico
Squatrito, Rosario
Casuccio, Alessandra
Pecoraro, Rosaria
Aiello, Anna
Pinto, Antonio
Accardi, Giulia
Corte, Vittoriano Della
Clemente, Giuseppe
Caruso, Calogero
Arnao, Valentina
Simonetta, Irene
Maida, Carlo
Author_xml – sequence: 1
  givenname: Antonino
  orcidid: 0000-0001-6440-7318
  surname: Tuttolomondo
  fullname: Tuttolomondo, Antonino
– sequence: 2
  givenname: Domenico
  surname: Di Raimondo
  fullname: Di Raimondo, Domenico
– sequence: 3
  givenname: Rosaria
  surname: Pecoraro
  fullname: Pecoraro, Rosaria
– sequence: 4
  givenname: Alessandra
  surname: Casuccio
  fullname: Casuccio, Alessandra
– sequence: 5
  givenname: Danilo
  surname: Di Bona
  fullname: Di Bona, Danilo
– sequence: 6
  givenname: Anna
  surname: Aiello
  fullname: Aiello, Anna
– sequence: 7
  givenname: Giulia
  surname: Accardi
  fullname: Accardi, Giulia
– sequence: 8
  givenname: Valentina
  surname: Arnao
  fullname: Arnao, Valentina
– sequence: 9
  givenname: Giuseppe
  surname: Clemente
  fullname: Clemente, Giuseppe
– sequence: 10
  givenname: Vittoriano Della
  surname: Corte
  fullname: Corte, Vittoriano Della
– sequence: 11
  givenname: Carlo
  surname: Maida
  fullname: Maida, Carlo
– sequence: 12
  givenname: Irene
  surname: Simonetta
  fullname: Simonetta, Irene
– sequence: 13
  givenname: Calogero
  surname: Caruso
  fullname: Caruso, Calogero
– sequence: 14
  givenname: Rosario
  surname: Squatrito
  fullname: Squatrito, Rosario
– sequence: 15
  givenname: Antonio
  surname: Pinto
  fullname: Pinto, Antonio
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30995924$$D View this record in MEDLINE/PubMed
BookMark eNp1ks1u1DAUhSNURNuBB2CDLLEpixT_JbE3SKMK6IiRkBCsLce5zngmsQcnKerb43Ra6FSgLBzZ53zJuT7n2YkPHrLsNcGXhIjy_UCorHiOicwJL2VePMvOSMVpTrHkJ4_eT7PzYdhizGhR0hfZKcNSFpLys8xdr5dI-wbtXNdBRAa6Drm-n3xou1BPnfN553aAIhjYjyGiiy-rb8M71IIP4-3e-RY5j_Z6dODHAf1y4wZpM42A3GA20DuDhjGGHbzMnlvdDfDqfl1kPz59_H51na-_fl5dLde5KUo85lZwYpuKWqGNBCmYrTiztsCGNVroUoIVGGgDFjCTDeG8glo0sxlTQxhbZKsDtwl6q_bR9TreqqCdutsIsVU6js50oKpaJpIwFjfAua2FIKysKK6KooDa4MT6cGDtp7qHxqSIUXdH0OMT7zaqDTeq5BWpEm2RXdwDYvg5wTCqPo0lzVh7CNOgKCWE0YrR-b_fPpFuwxR9GtWdimMhhfiranUK4LwN6btmhqplIRgRTCbYIrv8hyo9zXwhqUTWpf0jw5vHQf8kfChKElQHgYlhGCJYZdyYLj3MuV2nCFZzJdWhkipVUs2VVEVykifOB_j_Pb8Br-Xifg
CitedBy_id crossref_primary_10_1371_journal_pone_0240483
crossref_primary_10_3390_ijerph20021487
crossref_primary_10_3390_ijms21020606
crossref_primary_10_3390_ijms24108681
crossref_primary_10_1016_j_humgen_2022_201126
crossref_primary_10_1016_j_clnesp_2024_06_018
crossref_primary_10_3390_genes13060978
crossref_primary_10_1007_s11011_021_00792_7
crossref_primary_10_1038_s41392_021_00802_1
crossref_primary_10_31083_j_rcm2506199
crossref_primary_10_1007_s00251_023_01316_6
crossref_primary_10_1016_j_ejphar_2021_174360
crossref_primary_10_1097_MD_0000000000022465
crossref_primary_10_3390_ijms22094405
crossref_primary_10_3390_ph15101168
crossref_primary_10_2147_NDT_S265601
crossref_primary_10_2147_PGPM_S320483
crossref_primary_10_3390_idr16020029
crossref_primary_10_1038_s41598_024_83555_5
crossref_primary_10_3390_ijms25126297
crossref_primary_10_1080_01616412_2024_2340886
crossref_primary_10_1111_eci_13684
crossref_primary_10_3390_cells10092429
crossref_primary_10_3390_ijms25010061
crossref_primary_10_3390_ijms21186454
crossref_primary_10_3390_ijms24108619
crossref_primary_10_1007_s11011_021_00723_6
crossref_primary_10_2174_1381612826666200317142412
crossref_primary_10_1080_17501911_2024_2377947
crossref_primary_10_3390_ijms21207615
crossref_primary_10_3892_etm_2021_10919
crossref_primary_10_3389_fneur_2023_1207795
crossref_primary_10_3390_ijms23042306
crossref_primary_10_1016_j_neulet_2020_135616
crossref_primary_10_3390_diagnostics12061355
crossref_primary_10_1097_MD_0000000000026515
crossref_primary_10_1155_2022_1119611
crossref_primary_10_1186_s12915_022_01392_2
crossref_primary_10_1515_revneuro_2024_0128
crossref_primary_10_31083_j_jin_2021_01_228
crossref_primary_10_2174_138161282640201111114453
crossref_primary_10_1080_1744666X_2024_2392815
crossref_primary_10_3390_ijms21249372
crossref_primary_10_3390_genes13010048
crossref_primary_10_3390_ijms23052445
Cites_doi 10.1073/pnas.95.7.3798
10.1084/jem.184.2.789
10.4049/jimmunol.0804224
10.1126/science.274.5295.2097
10.1016/j.jneuroim.2009.06.019
10.1177/039463200601900320
10.1161/ATVBAHA.113.302163
10.1161/01.CIR.100.21.2135
10.1161/01.STR.24.1.35
10.1161/01.CIR.101.25.2883
10.2174/138161212802481200
10.1097/00007890-199912150-00024
10.1161/01.ATV.19.7.1595
10.1161/STR.0b013e318296aeca
10.1212/01.WNL.0000142260.61443.7C
10.1016/j.jacc.2006.08.051
10.1073/pnas.0712229105
10.1126/science.1097670
10.1016/j.cmet.2010.12.008
10.1016/j.cyto.2012.02.012
10.1042/CS20080372
10.1097/01.hjh.0000431740.32696.cc
10.4049/jimmunol.1302843
10.1146/annurev.immunol.23.021704.115526
10.1084/jem.193.10.1159
10.1038/nature03847
10.1172/JCI119465
10.4049/jimmunol.159.8.3723
10.1385/NMM:7:3:229
10.1016/j.ijcard.2010.06.005
10.1016/S1074-7613(00)80394-5
10.1159/000102163
10.1093/infdis/jiu226
10.1161/hs0202.103399
10.1038/nrcardio.2009.55
10.1016/j.coi.2005.03.006
10.4049/jimmunol.155.9.4139
10.1097/MD.0000000000000813
10.1016/j.cell.2010.08.031
10.1073/pnas.94.19.10285
10.1016/j.smim.2008.06.003
10.1002/eji.200425932
10.1002/1529-0131(200101)44:1<13::AID-ANR3>3.0.CO;2-6
10.1038/ni.2001
10.1161/circ.106.25.3143
10.1161/01.RES.0000082333.58263.58
10.1016/S0047-6374(97)00161-9
10.1016/S1357-4310(97)01077-0
ContentType Journal Article
Contributor Caruso, Calogero
Di Bona, Danilo
Tuttolomondo, Antonino
Di Raimondo, Domenico
Pinto, Antonio
Contributor_xml – sequence: 1
  givenname: Antonino
  surname: Tuttolomondo
  fullname: Tuttolomondo, Antonino
– sequence: 2
  givenname: Domenico
  surname: Di Raimondo
  fullname: Di Raimondo, Domenico
– sequence: 3
  givenname: Danilo
  surname: Di Bona
  fullname: Di Bona, Danilo
– sequence: 4
  givenname: Calogero
  surname: Caruso
  fullname: Caruso, Calogero
– sequence: 5
  givenname: Antonio
  surname: Pinto
  fullname: Pinto, Antonio
Copyright COPYRIGHT 2019 BioMed Central Ltd.
2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s). 2019
Copyright_xml – notice: COPYRIGHT 2019 BioMed Central Ltd.
– notice: 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s). 2019
CorporateAuthor on behalf of KIRIIND (KIR Infectious and Inflammatory Diseases) Collaborative Group
KIRIIND (KIR Infectious and Inflammatory Diseases) Collaborative Group
CorporateAuthor_xml – name: on behalf of KIRIIND (KIR Infectious and Inflammatory Diseases) Collaborative Group
– name: KIRIIND (KIR Infectious and Inflammatory Diseases) Collaborative Group
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7T5
7TK
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12974-019-1469-5
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Immunology Abstracts
Neurosciences Abstracts
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Proquest Medical Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Immunology Abstracts
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
Publicly Available Content Database
MEDLINE



Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1742-2094
EndPage 15
ExternalDocumentID oai_doaj_org_article_7b9e2d8cf0de44fb881367207555ebc0
PMC6471781
A583183932
30995924
10_1186_s12974_019_1469_5
Genre Journal Article
GeographicLocations Italy
GeographicLocations_xml – name: Italy
GroupedDBID ---
0R~
29L
2WC
53G
5GY
5VS
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
EJD
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
TR2
TUS
UKHRP
WOQ
WOW
XSB
~8M
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
3V.
7T5
7TK
7XB
8FK
AZQEC
DWQXO
H94
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c560t-f841fd72f8ac9e983f743ff50c3da8a69ef80e2defe039d1447eb8dc56002c133
IEDL.DBID DOA
ISSN 1742-2094
IngestDate Wed Aug 27 01:30:53 EDT 2025
Thu Aug 21 18:34:30 EDT 2025
Wed Jul 30 11:18:31 EDT 2025
Fri Jul 25 05:15:29 EDT 2025
Tue Jun 17 21:37:35 EDT 2025
Tue Jun 10 20:47:27 EDT 2025
Thu Apr 03 06:59:21 EDT 2025
Tue Jul 01 02:54:30 EDT 2025
Thu Apr 24 23:16:23 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords HLA
Stroke
Killer immunoglobulin-like receptors (KIRs)
Language English
License Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c560t-f841fd72f8ac9e983f743ff50c3da8a69ef80e2defe039d1447eb8dc56002c133
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-6440-7318
OpenAccessLink https://doaj.org/article/7b9e2d8cf0de44fb881367207555ebc0
PMID 30995924
PQID 2211408988
PQPubID 55345
PageCount 15
ParticipantIDs doaj_primary_oai_doaj_org_article_7b9e2d8cf0de44fb881367207555ebc0
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6471781
proquest_miscellaneous_2211327323
proquest_journals_2211408988
gale_infotracmisc_A583183932
gale_infotracacademiconefile_A583183932
pubmed_primary_30995924
crossref_citationtrail_10_1186_s12974_019_1469_5
crossref_primary_10_1186_s12974_019_1469_5
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-04-17
PublicationDateYYYYMMDD 2019-04-17
PublicationDate_xml – month: 04
  year: 2019
  text: 2019-04-17
  day: 17
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Journal of neuroinflammation
PublicationTitleAlternate J Neuroinflammation
PublicationYear 2019
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References 1469_CR31
A Tuttolomondo (1469_CR32) 2012; 58
1469_CR39
S Gupta (1469_CR3) 1997; 99
1469_CR36
1469_CR35
LL Lanier (1469_CR5) 2005; 23
A Tuttolomondo (1469_CR24) 2012; 18
G Liuzzo (1469_CR38) 1999; 100
G Licata (1469_CR26) 2006; 19
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (1469_CR12) 2002; 106
M Campanella (1469_CR15) 2002; 33
A Pinto (1469_CR25) 2009; 116
B Redmon (1469_CR10) 2014
1469_CR43
O Mandelboim (1469_CR42) 1998; 95
LE Rohde (1469_CR46) 1999; 19
A D'Andrea (1469_CR18) 1998; 230
RL Sacco (1469_CR9) 2013; 44
S Kulkarni (1469_CR6) 2008; 20
1469_CR44
G Mancia (1469_CR11) 2013; 31
RG Baker (1469_CR2) 2011; 13
VZ Rocha (1469_CR1) 2009; 6
VH Perry (1469_CR45) 1997; 3
A D’Andrea (1469_CR19) 1996; 184
JH Yen (1469_CR40) 2001; 193
O Mandelboim (1469_CR41) 1996; 274
1469_CR51
H Nakajima (1469_CR16) 1995; 155
DS Korbel (1469_CR22) 2009; 182
CS Witt (1469_CR23) 1999; 68
G Liuzzo (1469_CR34) 2000; 101
S Kim (1469_CR47) 2008; 105
1469_CR50
CM Weyand (1469_CR37) 1998; 102
1469_CR14
M Nowik (1469_CR30) 2007; 58
A Maria De (1469_CR20) 1997; 94
HP Adams Jr (1469_CR13) 1993; 24
ZG Nadareishvili (1469_CR29) 2004; 63
SI Khakoo (1469_CR49) 2004; 305
A Tuttolomondo (1469_CR27) 2009; 2015
S Kim (1469_CR48) 2005; 436
GK Hansson (1469_CR4) 2011; 12
1469_CR28
SGE Marsh (1469_CR33) 2002
T Nakajima (1469_CR7) 2003; 93
L Battistini (1469_CR17) 1997; 159
M Uhrberg (1469_CR21) 1997; 7
D Bona Di (1469_CR8) 2014; 210
References_xml – volume: 95
  start-page: 3798
  year: 1998
  ident: 1469_CR42
  publication-title: Proc Natl Acad Sci
  doi: 10.1073/pnas.95.7.3798
– volume: 184
  start-page: 789
  year: 1996
  ident: 1469_CR19
  publication-title: J Exp Med
  doi: 10.1084/jem.184.2.789
– volume: 182
  start-page: 6426
  issue: 10
  year: 2009
  ident: 1469_CR22
  publication-title: J Immunol
  doi: 10.4049/jimmunol.0804224
– volume: 274
  start-page: 2097
  year: 1996
  ident: 1469_CR41
  publication-title: Science
  doi: 10.1126/science.274.5295.2097
– volume: 2015
  start-page: 84
  issue: 1–2
  year: 2009
  ident: 1469_CR27
  publication-title: J Neuroimmunol
  doi: 10.1016/j.jneuroim.2009.06.019
– volume: 230
  start-page: 25
  year: 1998
  ident: 1469_CR18
  publication-title: Curr Top Microbiol Immunol
– volume: 19
  start-page: 639
  issue: 3
  year: 2006
  ident: 1469_CR26
  publication-title: Int J Immunopathol Pharmacol
  doi: 10.1177/039463200601900320
– ident: 1469_CR36
  doi: 10.1161/ATVBAHA.113.302163
– volume: 100
  start-page: 2135
  year: 1999
  ident: 1469_CR38
  publication-title: Circulation
  doi: 10.1161/01.CIR.100.21.2135
– volume: 24
  start-page: 35
  year: 1993
  ident: 1469_CR13
  publication-title: Stroke
  doi: 10.1161/01.STR.24.1.35
– volume: 101
  start-page: 2883
  year: 2000
  ident: 1469_CR34
  publication-title: Circulation
  doi: 10.1161/01.CIR.101.25.2883
– volume: 18
  start-page: 4289
  issue: 28
  year: 2012
  ident: 1469_CR24
  publication-title: Curr Pharm Des
  doi: 10.2174/138161212802481200
– volume: 68
  start-page: 1784
  year: 1999
  ident: 1469_CR23
  publication-title: Transplantation
  doi: 10.1097/00007890-199912150-00024
– volume: 19
  start-page: 1595
  year: 1999
  ident: 1469_CR46
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/01.ATV.19.7.1595
– volume: 44
  start-page: 2064
  issue: 7
  year: 2013
  ident: 1469_CR9
  publication-title: Stroke
  doi: 10.1161/STR.0b013e318296aeca
– volume: 63
  start-page: 1446
  year: 2004
  ident: 1469_CR29
  publication-title: Neurol
  doi: 10.1212/01.WNL.0000142260.61443.7C
– ident: 1469_CR39
  doi: 10.1016/j.jacc.2006.08.051
– volume: 105
  start-page: 3053
  issue: 8
  year: 2008
  ident: 1469_CR47
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0712229105
– volume: 305
  start-page: 872
  issue: 5685
  year: 2004
  ident: 1469_CR49
  publication-title: Science
  doi: 10.1126/science.1097670
– volume-title: Killer-cell immunoglobulin-like receptors (KIR) nomenclature report
  year: 2002
  ident: 1469_CR33
– volume: 13
  start-page: 11
  year: 2011
  ident: 1469_CR2
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2010.12.008
– volume: 58
  start-page: 398
  issue: 3
  year: 2012
  ident: 1469_CR32
  publication-title: Cytokine
  doi: 10.1016/j.cyto.2012.02.012
– volume: 116
  start-page: 781
  issue: 10
  year: 2009
  ident: 1469_CR25
  publication-title: Clin Sci
  doi: 10.1042/CS20080372
– volume: 31
  start-page: 1281
  issue: 7
  year: 2013
  ident: 1469_CR11
  publication-title: J Hypertens
  doi: 10.1097/01.hjh.0000431740.32696.cc
– ident: 1469_CR44
  doi: 10.4049/jimmunol.1302843
– volume: 23
  start-page: 225
  year: 2005
  ident: 1469_CR5
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev.immunol.23.021704.115526
– volume: 193
  start-page: 1159
  issue: 10
  year: 2001
  ident: 1469_CR40
  publication-title: J Exp Med
  doi: 10.1084/jem.193.10.1159
– volume: 436
  start-page: 709
  year: 2005
  ident: 1469_CR48
  publication-title: Nature
  doi: 10.1038/nature03847
– volume: 99
  start-page: 2752
  year: 1997
  ident: 1469_CR3
  publication-title: J Clin Invest
  doi: 10.1172/JCI119465
– volume: 159
  start-page: 3723
  issue: 8
  year: 1997
  ident: 1469_CR17
  publication-title: J Immunol
  doi: 10.4049/jimmunol.159.8.3723
– ident: 1469_CR28
  doi: 10.1385/NMM:7:3:229
– ident: 1469_CR14
  doi: 10.1016/j.ijcard.2010.06.005
– volume: 7
  start-page: 753
  year: 1997
  ident: 1469_CR21
  publication-title: Immunity
  doi: 10.1016/S1074-7613(00)80394-5
– volume: 58
  start-page: 26
  year: 2007
  ident: 1469_CR30
  publication-title: Eur Neurol
  doi: 10.1159/000102163
– volume: 210
  start-page: 1083
  issue: 7
  year: 2014
  ident: 1469_CR8
  publication-title: J Infect Dis
  doi: 10.1093/infdis/jiu226
– volume: 33
  start-page: 586
  year: 2002
  ident: 1469_CR15
  publication-title: Stroke
  doi: 10.1161/hs0202.103399
– volume: 6
  start-page: 399
  year: 2009
  ident: 1469_CR1
  publication-title: Nat Rev Cardiol
  doi: 10.1038/nrcardio.2009.55
– ident: 1469_CR35
  doi: 10.1016/j.coi.2005.03.006
– volume: 155
  start-page: 4139
  issue: 9
  year: 1995
  ident: 1469_CR16
  publication-title: J Immunol
  doi: 10.4049/jimmunol.155.9.4139
– ident: 1469_CR31
  doi: 10.1097/MD.0000000000000813
– ident: 1469_CR50
  doi: 10.1016/j.cell.2010.08.031
– volume: 94
  start-page: 10285
  year: 1997
  ident: 1469_CR20
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.94.19.10285
– volume: 20
  start-page: 343
  year: 2008
  ident: 1469_CR6
  publication-title: Semin Immunol
  doi: 10.1016/j.smim.2008.06.003
– ident: 1469_CR51
  doi: 10.1002/eji.200425932
– volume-title: Diagnosis and management of type 2 diabetes mellitus in adults
  year: 2014
  ident: 1469_CR10
– ident: 1469_CR43
  doi: 10.1002/1529-0131(200101)44:1<13::AID-ANR3>3.0.CO;2-6
– volume: 12
  start-page: 204
  year: 2011
  ident: 1469_CR4
  publication-title: Nat Immunol
  doi: 10.1038/ni.2001
– volume: 106
  start-page: 3143
  issue: 25
  year: 2002
  ident: 1469_CR12
  publication-title: Circulation
  doi: 10.1161/circ.106.25.3143
– volume: 93
  start-page: 106
  issue: 2
  year: 2003
  ident: 1469_CR7
  publication-title: Circ Res
  doi: 10.1161/01.RES.0000082333.58263.58
– volume: 102
  start-page: 131
  year: 1998
  ident: 1469_CR37
  publication-title: Mech Ageing Dev
  doi: 10.1016/S0047-6374(97)00161-9
– volume: 3
  start-page: 337
  year: 1997
  ident: 1469_CR45
  publication-title: Mol Med Today
  doi: 10.1016/S1357-4310(97)01077-0
SSID ssj0032562
Score 2.4556985
Snippet In humans, a major component of natural killer (NK) and T cell target recognition depends on the surveillance of human leukocyte antigen (HLA) class I...
Introduction In humans, a major component of natural killer (NK) and T cell target recognition depends on the surveillance of human leukocyte antigen (HLA)...
Abstract Introduction In humans, a major component of natural killer (NK) and T cell target recognition depends on the surveillance of human leukocyte antigen...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 88
SubjectTerms Aged
Alleles
Angina pectoris
Antigens
Arteriosclerosis
Atherosclerosis
Cardiovascular disease
Cloning
Cross-Sectional Studies
Cytomegalovirus
Development and progression
Diagnosis
Family medical history
Female
Gene frequency
Genetic aspects
Genetic Predisposition to Disease - genetics
Genotype
Genotyping
Heart attacks
Histocompatibility antigen HLA
Histocompatibility Antigens Class I - genetics
HLA
HLA antigens
Hospitals
Humans
Hypotheses
Immunoglobulin-like receptors
Immunoglobulins
Inflammation
Ischemia
Killer cell immunoglobulin-like receptors
Killer cells
Killer immunoglobulin-like receptors (KIRs)
Ligands
Lymphocytes
Lymphocytes T
Male
Middle Aged
Natural killer cells
Patients
Physiological aspects
Receptors, KIR - genetics
Rheumatoid arthritis
Stroke
Stroke - genetics
Stroke - immunology
Target recognition
SummonAdditionalLinks – databaseName: ProQuest Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bi9QwFA66gvgi3q2uEkHwAmUzSZukTzKKy3hZH8SFeQttLlpmacdp58F_7zltpm4R9rVJStOTc_mSc74Q8tKLnLmMq9RbCQDFC5cWNmOp5bkAh6VKz7Ea-eybXJ1nn9f5Om64dTGt8mATB0PtWot75CcckErGdKH1u-3vFG-NwtPVeIXGdXIDqcswpUutJ8AlwJ3zeJK50PKkA9-mMOeiSME-FGk-80UDZf__hvmSZ5pnTV5yQ6d3yO0YP9LlKPC75Jpv7pGbZ_GE_D6pV1-XtGwc3QxFfhQ35mmNRSAtcn9g3nl6UW88BUvntwC46esvn753byiStfZ_sHqK1g2NdKsdxX1aWtp972kNQBhT6WnX79qNf0DOTz_--LBK43UKqYWwpk-DzhbBKR50aQtfaBFAGCHkzApX6lIWPmjmufPBM1E4QFrKV9rhYMYtYNmH5KhpG_-Y0EwK4SS8SeYAJ7ktg5LlAvzhonLOCZ0Qdvixxkaucbzy4sIMmENLM8rCgCwQfBQmT8jbach2JNq4qvN7lNbUETmyhwft7qeJKmdUVcBstA3M-SwLldZIT8chRspzX1mWkFcoa4OaDB9ny1iQAFNETiyzzDUaPAhwE3I86wkaaOfNh9ViogXozL_1mpAXUzOOxKy2xrf7sY-A-JGLhDwaF9c0JcGQCY5nCVGzZTeb87ylqX8N_OASAg6lF0-u_qyn5BZHVUDeSnVMjvrd3j-DAKuvng9a9BeOmyPg
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEA_nCeKL-G31lAiCH1AvmzRN-iCyisf6sT6IC_cW2nxo2aU9t13w_ntn2m654uGTr02mNPORmWlmfiHkmReSuYSr2NsUEhQvXJzZhMWWSwEOS-WeYzfy8mu6WCWfTuXpAdlfbzUwsLk0tcP7pFbbzevfv87fgsG_6Qxep8cN-CyFtRRZDHafxfIKuQqOSaGdLpPxUEGAd-fDwealZBPX1CH4_71PX3BU0yLKC17p5Ca5MYSTdN7L_xY58NVtcm05HJjfIeXiy5zmlaPrrueP4n96WmJPSI1QIFiGHm_Ktaew8fkzyL_pi88fvzUvKWK3tufYTEXLig7oqw3F37Y0t7vW0xKYh5X1tGm39drfJauTD9_fL-LhdoXYQpTTxkEns-AUDzq3mc-0CCCbECSzwuU6TzMfNPPc-eCZyBwkXsoX2iEx4xZS23vksKor_4DQJBXCpfCmVEJ2yW0eVJrPwD3OCuec0BFhe8YaO0CP4w0YG9OlIDo1vSwMyAJzkczIiLwaSc563I1_TX6H0honImR296De_jCDBRpVZLAabQNzPklCoTWi1XEImaT0hWUReY6yNqhq8HE2H_oTYIkIkWXmUuP-B_FuRI4mM8Eg7XR4ry1mr8-GQ6KdMJ1pYMbTcRgpscit8vWunyMgnOQiIvd75RqXJBgCw_EkImqidpM1T0eq8mcHF55C_KH07OH_YNIjcp2jwSDYpToih-125x9DVNYWTzpb-wPHSjP3
  priority: 102
  providerName: Scholars Portal
Title HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute ischemic stroke
URI https://www.ncbi.nlm.nih.gov/pubmed/30995924
https://www.proquest.com/docview/2211408988
https://www.proquest.com/docview/2211327323
https://pubmed.ncbi.nlm.nih.gov/PMC6471781
https://doaj.org/article/7b9e2d8cf0de44fb881367207555ebc0
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Ja9wwFBZtCqWX0r1u0kGFQhcwkSVr8XFSEqbLhBIamJuwtRAzwRMynkP_fd6zPcOYQnvpxQdLMtbT2z776RMh74OQzOdcp8EpAChB-LRwOUsdlwICli4Dx93I83M1u8y_LeRi76gvrAnr6YF7wR3rqgjcGxeZD3keK2OQZIxDpJMyVK5D6xDztmCq98ECAjkf_mFmRh2vIapprLYoUvAMRSpHUagj6__TJe_FpHG95F4AOntCHg-ZI532b_yU3AvNM_JwPvwbf07q2Y8pLRtPl932Poqf5GmN2z9WyPqBFefpdb0MFHxcuAGoTT9-_3qx_kSRprX9jfumaN3QgWh1TfELLS3dpg20BgiMRfR03d6uluEFuTw7_fVllg4HKaQOEpo2jSbPotc8mtIVoTAiwjLEKJkTvjSlKkI0DKQcYmCi8ICxdKiMx8GMO0CxL8lBs2rCa0JzJYRX8CQlAUhyV0atygwiYVZ574VJCNsK1rqBZRwPu7i2HdowyvZrYWEtEHYUVibk827ITU-x8bfOJ7hau47Ijt3dAJ2xg87Yf-lMQj7gWlu0YXg5Vw5bEWCKyIZlp9Kgq4PUNiFHo55ge27cvNUWO9j-2nLA1DkzhQFhvNs140isZ2vCatP3EZA5cpGQV71y7aYkGHLA8TwheqR2ozmPW5r6qmMGV5BqaJO9-R9COiSPOBoM8lrqI3LQ3m7CW0jA2mpC7uuFnpAHJ6fnPy8mneXBdZ6bO901L94
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLamTgJeEHcCA4wE4iJFc-xcnAeEOtjU0ovQtEl78xLbgahTUppUaH-K38g5TVIWIe1tr7Vd2Tl3-5zvEPLGioAZn0eu1SEEKFYYN9Y-czUPBBisKLEcq5Fn83B06n87C852yJ-uFgbTKjuduFHUptR4R77PIVLxmYyl_Lz85WLXKHxd7VpoNGwxsZe_IWSrPo2_An3fcn50ePJl5LZdBVwN1r12M-l7mYl4JhMd21iKDPaUZQHTwiQyCWObSWa5sZllIjYQcEQ2lQYXM649vAAFlb_rCwhlBmT34HD-_bjT_QIcCN6-nXoy3K_AmkaY5RG7oJFiN-hZv02TgP9NwRVb2M_TvGL4ju6Ru63HSocNi90nO7Z4QG7N2jf5hyQfTYc0KQxdbMoKKT4F0BzLTkpEG8FMd_ciX1gKutUuIcSn7yfj4-oDRXjY-hLrtWhe0BbgtaJ4M0wTva4tzSH0xuR9WtWrcmEfkdMb-dSPyaAoC_uUUD8UwoTwT2EAASzXSRaFiQcW2EuNMUI6hHUfVukW3RybbFyoTZQjQ9XQQgEtMNyJVeCQj9slywba47rJB0it7URE5d78UK5-qFbIVZTGcBqpM2as72eplAiIx8ErCwKbauaQd0hrhboDNqeTtgQCjogoXGoYSFSx4FI7ZK83E2Re94c7blGtzqnUPwlxyOvtMK7EPLrClutmjgCPlQuHPGmYa3skwRB7jvsOiXps1ztzf6TIf24QyUNwcSLpPbt-W6_I7dHJbKqm4_nkObnDUSwQNTPaI4N6tbYvwL2r05etTFFyftNi_BfI1mMt
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=HLA+and+killer+cell+immunoglobulin-like+receptor+%28KIRs%29+genotyping+in+patients+with+acute+ischemic+stroke&rft.jtitle=Journal+of+neuroinflammation&rft.au=Antonino+Tuttolomondo&rft.au=Domenico+Di+Raimondo&rft.au=Rosaria+Pecoraro&rft.au=Alessandra+Casuccio&rft.date=2019-04-17&rft.pub=BMC&rft.eissn=1742-2094&rft.volume=16&rft.issue=1&rft.spage=1&rft.epage=15&rft_id=info:doi/10.1186%2Fs12974-019-1469-5&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_7b9e2d8cf0de44fb881367207555ebc0
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1742-2094&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1742-2094&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1742-2094&client=summon